Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31629006)

  • 1. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.
    Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG
    Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans.
    Rathmacher JA; Fuller JC; Abumrad NN; Flynn CR
    Inflammation; 2023 Aug; 46(4):1343-1352. PubMed ID: 36935449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
    Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
    Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes.
    Subati T; Yang Z; Murphy MB; Stark JM; Trykall DZ; Davies SS; Barnett JV; Murray KT
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.
    May-Zhang LS; Yermalitsky V; Huang J; Pleasent T; Borja MS; Oda MN; Jerome WG; Yancey PG; Linton MF; Davies SS
    J Biol Chem; 2018 Jun; 293(24):9176-9187. PubMed ID: 29712723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
    Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
    Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolevuglandins and cardiovascular disease.
    Davies SS; May-Zhang LS
    Prostaglandins Other Lipid Mediat; 2018 Nov; 139():29-35. PubMed ID: 30296489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr
    Tao H; Huang J; Yancey PG; Yermalitsky V; Blakemore JL; Zhang Y; Ding L; Zagol-Ikapitte I; Ye F; Amarnath V; Boutaud O; Oates JA; Roberts LJ; Davies SS; Linton MF
    Nat Commun; 2020 Aug; 11(1):4084. PubMed ID: 32796843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scavenging Reactive Lipids to Prevent Oxidative Injury.
    May-Zhang LS; Kirabo A; Huang J; Linton MF; Davies SS; Murray KT
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():291-308. PubMed ID: 32997599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scavenging 4-Oxo-2-nonenal.
    Amarnath V; Amarnath K
    Chem Res Toxicol; 2015 Oct; 28(10):1888-90. PubMed ID: 26355561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.
    Longato L; Andreola F; Davies SS; Roberts JL; Fusai G; Pinzani M; Moore K; Rombouts K
    Free Radic Biol Med; 2017 Jan; 102():162-173. PubMed ID: 27890721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry and analysis of HNE and other prominent carbonyl-containing lipid oxidation compounds.
    Sousa BC; Pitt AR; Spickett CM
    Free Radic Biol Med; 2017 Oct; 111():294-308. PubMed ID: 28192230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
    Hartley DP; Kroll DJ; Petersen DR
    Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells.
    Maulucci G; Daniel B; Cohen O; Avrahami Y; Sasson S
    Mol Aspects Med; 2016 Jun; 49():49-77. PubMed ID: 27012748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adducts.
    Rohn TT; Nelson LK; Waeg G; Quinn MT
    Biochem Pharmacol; 1998 Nov; 56(10):1371-9. PubMed ID: 9825737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effect of protein modifications by lipid peroxidation products.
    Gęgotek A; Skrzydlewska E
    Chem Phys Lipids; 2019 Jul; 221():46-52. PubMed ID: 30922835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.
    Singh M; Kapoor A; Bhatnagar A
    Chem Biol Interact; 2015 Jun; 234():261-73. PubMed ID: 25559856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified LC/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples.
    Yermalitsky VN; Matafonova E; Tallman K; Li Z; Zackert W; Roberts LJ; Amarnath V; Davies SS
    Anal Biochem; 2019 Feb; 566():89-101. PubMed ID: 30458125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry.
    Bruenner BA; Jones AD; German JB
    Chem Res Toxicol; 1995 Jun; 8(4):552-9. PubMed ID: 7548735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolevuglandins as a gauge of lipid peroxidation in human tumors.
    Yan HP; Roberts LJ; Davies SS; Pohlmann P; Parl FF; Estes S; Maeng J; Parker B; Mernaugh R
    Free Radic Biol Med; 2017 May; 106():62-68. PubMed ID: 28189846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.